SCHEMBL17075133

SCHEMBL17075133

NC(=O)CN1CC=C(C2CC2)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ MAPT P10636 4/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ BLM P54132 2/20 0.32
▸ APEX1 P27695 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ S100A4 P26447 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403878 0.66 LMNA (0.46) ALDH1A1HPGDTSHRSCN5ASCN9A
Bromide SCHEMBL28230837 0.64 CA12 (0.40) ALDH1A1MAPTKMT2AKDM4ETSHR
SCHEMBL15522705 0.64 GPBAR1 (0.41) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL17075236 0.63 CYP2C19 (0.40) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL4872142 0.62 SIGMAR1 (0.35) SIGMAR1KMT2AHPGDTDP1CYP2C19
SCHEMBL17075119 0.62 ALDH1A1 (0.40) SIGMAR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6025353 0.62 ALDH1A1 (0.62) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL17075184 0.61 ALDH1A1 (0.39) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL10437124 0.61 PTPN1 (0.39) ALDH1A1MAPTHPGDALOX15HSD17B10
SCHEMBL5034166 0.61 KDM4E (0.60) MAPTMEN1KMT2AKDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116873-B1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2018-02-28 — — EP disclosed
US-20170158693-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2017-06-08 — — US disclosed
US-9573950-B2 Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2017-02-21 — — US disclosed
EP-3116873-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2017-01-18 — — EP disclosed
US-20150259343-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 — — US disclosed
WO-2015136090-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158693-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL HTR2C, HTR2A, HTR5A SIGMAR1 204/4885ALDH1A1 949/4885MAPT 3762/4885
US-20150259343-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL HTR2C, HTR2A, HTR5A SIGMAR1 204/4885ALDH1A1 949/4885MAPT 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback